Semizlikdan qutulish yöllari: parhez, maşqlar va farmakologik ususllarning biokimyoviy asoslari

Authors

  • Kuranova Sevara Saidolimovna Andijon davlat tibbiyot instituti Biologik kimyo kafedrasi katta öqituvchisi Author
  • Ikramova Mahliyo Ibrohimjon qizi Andijon davlat tibbiyot instituti talabasi Author
  • Abdumutalipov Fayzullo Baxtiyorjon öğli Andijon davlat tibbiyot instituti talabasi Author
  • Abdullayev MuhammadQodir Dilyorbek ögʻli Andijon davlat tibbiyot instituti talabasi Author

Keywords:

semizlik, energiya balansi, lipoliz, insulin, leptin, GLP-1, parhez, jismoniy faollik.

Abstract

Maqolada semizlikni bartaraf etişning asosiy yönalişlari (parhez, jismoniy faollik va farmakologik usullar) biokimyoviy nuqtai nazardan tahlil qilinadi. Energiya balansi, lipogenez va lipoliz jarayonlari, şuningdek insulin, leptin, grelin va inkretin gormonlarining roli yoritiladi. Tahlil şuni körsatadiki, samarali va barqaror natija köpincha bir usulga emas, balki ularning birgalikdagi qöllanilişiga boğliq.

References

1.World Health Organization. Obesity and overweight (Fact sheet). Geneva: WHO.

2.Hall K.D., Kahan S. Maintenance of lost weight and long-term management of obesity.

3.Medical Clinics of North America, 2018; 102(1): 183–197.

4.Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals.

5.Nature, 1998; 395: 763–770.

6.Donnelly J.E. et al. ACSM Position Stand: Appropriate physical activity intervention

strategies for weight loss and prevention of weight regain for adults. Medicine &

Science in Sports & Exercise, 2009; 41(2): 459–471.

7.Wilding J.P.H. et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021; 384: 989–1002.

8.JastreboffA.M. et al. Tirzepatide once weekly for the treatment of obesity. New

England Journal of Medicine, 2022; 387: 205–216.

9.Sjöström L. et al. Effects of bariatric surgery on mortality in Swedish obese subjects.

New England Journal of Medicine, 2007; 357: 741–752.

10.Knowler W.C. et al. Reduction in the incidence of type 2 diabetes with lifestyle

intervention or metformin. New England Journal of Medicine, 2002; 346: 393–403.

Downloads

Published

2026-11-14